Nobuhiko Tanigawa
Overview
Explore the profile of Nobuhiko Tanigawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
2036
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshida R, Yamana H, Hayashi M, Yasuda E, Shibayama Y, Hirose Y, et al.
J Interferon Cytokine Res
. 2021 Sep;
41(9):310-318.
PMID: 34543129
Graft-versus-host disease (GVHD) is a physiological response of the graft to allogeneic hosts. However, the effector cells, affected organ(s), and cytokines in the GVHD remain controversially discussed, without having determined...
2.
Tanigawa N, Yamaue H, Ohyama S, Sakuramoto S, Inada T, Kodera Y, et al.
Gastric Cancer
. 2015 Sep;
19(2):350-360.
PMID: 26385385
Background: Although postoperative adjuvant chemotherapy with S-1, an oral fluoropyrimidine, has become a standard of care for gastric cancer in Japan, nonresponders may suffer from the cost and adverse reactions...
3.
Yokoyama K, Tanigawa N, Ogata A, Nagai T, Higashino M
Surg Laparosc Endosc Percutan Tech
. 2015 Aug;
25(4):e129-33.
PMID: 26241299
Background And Aim: Between January 2012 and June 2013, we performed laparoscopic choledocholithotomy on 10 cases of common bile duct stone disease. Laparoscopic surgery for common duct stone disease is...
4.
Takahari D, Hamaguchi T, Yoshimura K, Katai H, Ito S, Fuse N, et al.
Gastric Cancer
. 2013 May;
17(2):383-6.
PMID: 23719867
Background: We previously reported that S-1 plus cisplatin was feasible as adjuvant chemotherapy for stage III gastric cancer after D2 gastrectomy. Herein we evaluate the recurrence-free survival and overall survival...
5.
Ueda H, Tanaka H, Ichikawa K, Itabashi M, Kameoka S, Fujii S, et al.
Surg Today
. 2013 Jan;
43(11):1275-80.
PMID: 23307264
Purpose: Making a clinicopathological diagnosis of dysplasia is crucial. We herein assess the significance of the DNA methyltransferase 3b (DNMT3b) expression as a diagnostic marker of ulcerative colitis (UC)-associated neoplasia....
6.
Lee S, Tanigawa N, Nomura E, Tokuhara T, Kawai M, Yokoyama K, et al.
World J Surg Oncol
. 2012 Dec;
10:267.
PMID: 23232031
Background: Laparoscopic gastrectomy has recently been gaining popularity as a treatment for cancer; however, little is known about the benefits of intracorporeal (IC) gastrointestinal anastomosis with pure laparoscopic distal gastrectomy...
7.
Sumiyoshi K, Nohara T, Iwamoto M, Tanaka S, Kimura K, Takahashi Y, et al.
Exp Ther Med
. 2012 Sep;
1(4):641-645.
PMID: 22993587
In breast-conserving surgery, positive margins are closely related to intramammary recurrence, but methods of assessing resection stumps during breast-conserving surgery have not been standardized. The present study investigated the usefulness...
8.
Nohara T, Iwamoto M, Sumiyoshi K, Tanaka S, Kimura K, Takahashi Y, et al.
Oncol Lett
. 2012 Sep;
1(4):669-672.
PMID: 22966361
This study examined the therapeutic efficacy of TS-1 in the treatment of locally recurrent breast cancer. Between August 2006 and May 2009, 7 patients with local breast cancer recurrences were...
9.
Tanaka S, Nohara T, Iwamoto M, Sumiyoshi K, Kimura K, Takahashi Y, et al.
Oncol Lett
. 2012 Sep;
1(1):99-101.
PMID: 22966264
Immediate breast reconstruction following mastectomy is an effective treatment for breast cancer patients. Among several implant options, a latissimus dorsi myocutaneous (LDM) flap is used mainly due to the ease...
10.
Shimizu T, Hayashi M, Inoue Y, Komeda K, Asakuma M, Hirokawa F, et al.
Ann Transplant
. 2012 Jun;
17(2):122-6.
PMID: 22743730
Background: As newer immunosuppressive regimens have steadily reduced in the incidence of acute rejection and have extended the life expectancy of allograft recipients, posttransplant de novo malignancies have become an...